Showing results (221-230 of 585) with videos related to

Sort By:
Pageof 59
British Journal of Pharmacology|July 2, 2010
Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current statusTerry K W Ma, Kevin K H Kam, Bryan P Yan, et al.
Infectious Diseases and Therapy|September 10, 2025
Cardiovascular Safety of COVID-19 Treatments: A Disproportionality Analysis of Adverse Event Reports from the WHO VigiBaseHoi K Cheng, Angel Lai, Maxwell Kwok, et al.
Current Allergy and Asthma Reports|October 24, 2025
Using the Electronic Health Record to Facilitate Drug Allergy DelabelingMatthew J Molloy, Adam P Yan, Averi E Wilson, et al.
Optics Express|May 4, 2016
Bidirectional pumped high power Raman fiber laserQ Xiao, P Yan, D Li, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 22, 2008
Combined pharmacomechanical thrombectomy for acute inferior vena cava filter thrombosisBryan P Yan, Thomas J Kiernan, Vishal Gupta, et al.
International Journal of Cardiology|November 11, 2017
Real-world study of low-density lipoprotein cholesterol levels and cardiovascular outcomes in Chinese: A retrospective cohort study in post-percutaneous coronary intervention acute coronary syndrome patientsYun Wang, Bryan P Yan, Michael B Nichol, et al.
Journal of Animal Science|February 14, 2009
Heat-stress-induced damage to porcine small intestinal epithelium associated with downregulation of epithelial growth factor signalingF Liu, J Yin, M Du, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|October 11, 2013
Wearable cuff-less PTT-based system for overnight blood pressure monitoringYali Zheng, Bryan P Yan, Yuanting Zhang, et al.
Genetics and Molecular Research : GMR|November 5, 2014
Role of MshQ in MSHA pili biosynthesis and biofilm formation of Aeromonas hydrophilaY X Qin, Q P Yan, X X Mao, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 26, 2011
DURATION-2: efficacy and safety of switching from maximum daily sitagliptin or pioglitazone to once-weekly exenatideC Wysham, R Bergenstal, J Malloy, et al.
Pageof 59